IDH-mutant glioma samples showed increased levels of 2-HG ([M-H]-, m/z 147) and decreased levels of glutamic acid ([M-H]-, m/z 146) and xanthine ([M-H]-, m/z 151) compared to wildtype gliomas (Figure 4G, Figure S9). The gene discussed is IDH1; the disease is central nervous system cancer.